CERBAI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.182
EU - Europa 14.474
AS - Asia 9.219
SA - Sud America 1.098
AF - Africa 284
OC - Oceania 190
Continente sconosciuto - Info sul continente non disponibili 2
Totale 46.449
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.955
RU - Federazione Russa 4.320
IT - Italia 3.288
SG - Singapore 2.723
PL - Polonia 2.614
CN - Cina 1.988
HK - Hong Kong 1.538
IE - Irlanda 1.065
VN - Vietnam 944
BR - Brasile 899
SE - Svezia 815
KR - Corea 773
DE - Germania 495
FR - Francia 430
FI - Finlandia 425
GB - Regno Unito 332
IN - India 324
UA - Ucraina 300
AU - Australia 184
JP - Giappone 171
JO - Giordania 146
TR - Turchia 134
CA - Canada 121
ID - Indonesia 104
BD - Bangladesh 102
AR - Argentina 82
CI - Costa d'Avorio 78
NL - Olanda 73
CH - Svizzera 65
IQ - Iraq 64
MX - Messico 64
ES - Italia 59
BE - Belgio 54
NG - Nigeria 54
ZA - Sudafrica 50
EC - Ecuador 32
AT - Austria 29
LT - Lituania 22
VE - Venezuela 22
PK - Pakistan 21
PH - Filippine 20
SC - Seychelles 20
CL - Cile 18
CO - Colombia 18
GR - Grecia 18
MA - Marocco 18
SA - Arabia Saudita 18
UZ - Uzbekistan 17
RO - Romania 15
DZ - Algeria 14
TH - Thailandia 14
TW - Taiwan 14
MY - Malesia 12
PY - Paraguay 12
CZ - Repubblica Ceca 11
KE - Kenya 11
EG - Egitto 10
NP - Nepal 10
TN - Tunisia 10
IL - Israele 9
KZ - Kazakistan 9
PE - Perù 9
AZ - Azerbaigian 8
JM - Giamaica 8
BJ - Benin 6
DO - Repubblica Dominicana 6
IR - Iran 6
KW - Kuwait 6
OM - Oman 6
CR - Costa Rica 5
NZ - Nuova Zelanda 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
BY - Bielorussia 4
DK - Danimarca 4
GE - Georgia 4
GT - Guatemala 4
HN - Honduras 4
HU - Ungheria 4
LB - Libano 4
NO - Norvegia 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BB - Barbados 3
BH - Bahrain 3
KG - Kirghizistan 3
MN - Mongolia 3
PA - Panama 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BW - Botswana 2
ET - Etiopia 2
EU - Europa 2
LC - Santa Lucia 2
LK - Sri Lanka 2
Totale 46.415
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.734
Ashburn 2.603
Warsaw 2.603
Singapore 1.962
Fairfield 1.918
Hong Kong 1.283
Chandler 1.089
Dublin 1.056
Woodbridge 928
Cambridge 789
Seattle 779
Seoul 762
Houston 706
Milan 665
San Jose 648
Wilmington 635
Beijing 501
Jacksonville 422
Ann Arbor 412
Florence 393
Altamura 348
Lawrence 348
The Dalles 326
Hefei 302
Princeton 290
Ho Chi Minh City 280
Rome 266
Dallas 264
Buffalo 263
Los Angeles 256
Lauterbourg 243
Boston 223
Boardman 207
Hanoi 196
Mumbai 190
Munich 183
Moscow 180
Melbourne 167
Council Bluffs 166
Tokyo 158
New York 131
San Diego 127
Medford 125
Helsinki 112
Izmir 97
Shanghai 96
Falls Church 94
São Paulo 87
Paris 83
Abidjan 78
Kent 76
London 72
Jakarta 71
Turku 69
Norwalk 67
Bern 62
Dong Ket 62
Naples 60
Bologna 57
Redondo Beach 57
Frankfurt am Main 54
Abuja 52
Orem 52
Brussels 51
Guangzhou 49
Turin 49
Clifton 48
Chicago 47
Toronto 44
Figino 41
Haiphong 39
Da Nang 35
Dearborn 35
Phoenix 35
Montreal 34
Chennai 33
Tianjin 31
Hillsboro 30
Amsterdam 29
Columbus 29
Palermo 28
Andover 26
Yubileyny 26
Johannesburg 25
Miano 25
Venice 25
Mexico City 23
Poplar 23
Atlanta 22
Rio de Janeiro 22
Brasília 21
Vienna 21
Baghdad 20
Belo Horizonte 20
Brooklyn 20
Denver 20
Falkenstein 20
Genoa 20
Manchester 20
Scandicci 19
Totale 31.690
Salva come PNG Salva come JPEG
Nome #
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 484
Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy. 432
Atrial Remodeling in Hypertrophic Cardiomyopathy 402
Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation. 374
Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes 360
Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: A comparison of the cardiac troponin T E163R and R92Q mouse models 352
Mesoscopic optical imaging of whole mouse heart 349
Pharmacological perspectives in sarcopenia: A potential role for renin-angiotensin system blockers? 340
Regulation of intracellular Na+ in health and disease: pathophysiological mechanisms and implications for treatment 325
New isoform-selective HCN blockers 324
Myocardial Dysfunction in Hypertrophic Cardiomyopathy: Primary Effects of Sarcomeric Mutations Versus Secondary EC-Coupling Remodelling 302
Late sodium current inhibitors to treat exercise induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium. 299
Growth Factor-Induced Mobilization of Cardiac Progenitor Cells Reduces the Risk of Arrhythmias, in a Rat Model of Chronic Myocardial Infarction 294
Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy 291
Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach 290
Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats 284
Optical investigation of action potential and calcium handling maturation of hiPSC-cardiomyocytes on biomimetic substrates 281
T-Tubular Electrical Defects Contribute to Blunted β-Adrenergic Response in Heart Failure. 280
Altered Ca2+ and Na+ homeostasis in human hypertrophic cardiomyopathy: Implications for arrhythmogenesis 278
Antiarrhythmic properties of naloxone: an electrophysiological study on sheep cardiac Purkinje fibers 274
Mathematical modelling of the action potential of human embryonic stem cell derived cardiomyocytes. 272
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 271
Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents. 269
Modelling genetic diseases for drug development: Hypertrophic cardiomyopathy 265
Quantitative assessment of passive electrical properties of the cardiac T-tubular system by FRAP microscopy 264
Losartan ameliorates diabetic vascular hyper-reactivity to angiotensin II by reducing ROCK1 expression and activity 262
The funny current in cardiac non-pacemaker cells: functional role and pharmacological modulation 259
Angiotensin-II drives human satellite cells toward hypertrophy and myofibroblast trans-differentiation by two independent pathways 259
Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study 246
Design, synthesis and preliminary biological evaluation of new isoform-selective f-current blockers. 245
Design of muscle contraction assist devices by liquid crystalline elastomers 243
Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair 242
Development of Light-Responsive Liquid Crystalline Elastomers to Assist Cardiac Contraction 235
Cardiac effects of 3-iodothyronamine: A new aminergic system modulating cardiac function 231
Action potential propagation in transverse-axial tubular system is impaired in heart failure 230
Real-time optical manipulation of cardiac conduction in intact hearts 228
Selective Blockade of HCN1/HCN2 Channels as a Potential Pharmacological Strategy Against Pain 226
Ethical-legal aspects of organoids and their use in research. Manage risks and legal constraints for the development of ethical research 223
Electrophysiological Characterization of Isolated Human Atrial Myocytes Exposed to Tegaserod 222
Arrhythmia susceptibility in a rat model of acute atrial dilation 222
Ranolazine normalizes action potential duration in angiotensin II exposed HL-1 cells: role of late sodium current 220
Prenatal exposure to carbon monoxide delays postnatal cardiac maturation. 217
Modulation of Cardiac Ionic Homeostasis by 3-Iodothyronamine. 216
Design, synthesis and preliminary biological evaluation of zatebradine analogues as potential blockers of the hyperpolarization-activated current 213
Long term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression. 213
A molecular basis for HCN channel over-expression. 210
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 208
ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. 208
Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy 207
Molecular and functional development of cardiomyocytes differentiated from human embryonic stem cells. 205
The effect of losartan treatment on the response of diabetic cardiomyocytes to ATP depletion 204
Novel sulfamide-containing compounds as selective carbonic anhydrase i inhibitors 202
Acute appendicitis in a patient immunised with COVID-19 vaccine: a case report with morphological analysis 202
Chronic Atrial Fibrillation Alters the Functional Properties of Ifin the Human Atrium 201
Enhanced ROS production by NADPH oxidase is correlated to changes in antioxidant enzyme activity in human heart failure 199
Impact of detubulation on force and kinetics of cardiac muscle contraction 197
The transverse-axial tubular system of cardiomyocytes. 196
SELECTIVITY OF DIFFERENT CALCIUM ANTAGONISTS ON T- AND L-TYPE CALCIUM CURRENTS IN GUINEA-PIG VENTRICULAR MYOCYTES. 192
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 190
Expression of the hyperpolarization-activated current, I(f), in cultured adult rat ventricular cardiomyocytes and its modulation by hypertrophic factors 190
Late Sodium Current Inhibition Reverses Electro-Mechanical Dysfunction in Human Hypertrophic Cardiomyopathy 190
Functional expression and subcellular localization of f-channels in native human and HESC-derived cardiomyocytes 189
Pharmacological inhibition of serine proteases to reduce cardiac inflammation and fibrosis in atrial fibrillation 189
New phenylalkylamines as isoform selective HCN-Channels blockers 188
Prenatal exposure to carbon monoxide affects postnatal cellular electrophysiological maturation of the rat heart: a potential substrate for arrhythmogenesis in infancy 188
Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: dissecting the role of cardiac alternans in terminating rapid rhythms 187
Whole heart cytoarchitecture at micron-scale resolution 187
Atrial natriuretic peptide modulates the hyperpolarization-activated current (I(f)) in human atrial myocytes. 187
Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling 187
NADPH oxidase-dependent redox signaling in human heart failure: relationship between the left and right ventricle. 186
Tension generation and relaxation in single myofibrils from human atrial and ventricular myocardium. 185
Design of Biocompatible Liquid Cristal Elastomers Reproducing the Mechanical Properties of Human Cardiac Muscle 185
Optical clearing in cardiac imaging: A comparative study 185
R4496C RyR2 mutation impairs atrial and ventricular contractility 182
5-HT2 receptors enable cardiac differentiation of mouse embryonic stem cells 182
AUTONOMIC NERVOUS SYSTEM AND ARRHYTHMOGENESIS 181
Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry 179
CHARACTERISTICS OF L-TYPE CALCIUM CHANNEL BLOCKADE BY LACIDIPINE IN GUINEA-PIG VENTRICULAR MYOCYTES 179
If channels as a therapeutic target in heart disease 179
Electrophysiological effects mediated by the stimulation of cardiac β2-adrenoceptors with tulobuterol 179
Endothelin-1 promotes cellular electrophysiological remodeling by affecting IKr expression in cardiac HL-1 cells. 179
Molecular basis of funny current (If) in normal and failing human heart. 178
EC18 as a Tool To Understand the Role of HCN4 Channels in Mediating Hyperpolarization-Activated Current in Tissues 178
Update on antithrombotic therapy and body mass. A Clinical consensus Statement of the ESC Working Group on Cardiovascular Pharmacotherapy and the ESC Working Group on Thrombosis 175
Functional remodeling in post-myocardial infarcted rats: focus on beta-adrenoceptor subtypes. 174
Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: From molecular mechanisms to therapeutic implications 174
Microled Illumination Towards Liquid Crystalline Elastomers Based Cardiac Contraction Assistance 174
Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies 174
Reply to entcheva: The impact of T-tubules on action potential propagation in cardiac tissue 173
Optogenetic confirmation of transverse‐tubular membrane excitability in intact cardiac myocytes 172
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction 172
Action potential modelling predicts electrophysiological and pharmacological features of human embryonic stem cell-derived cardiomyocytes. 171
Defects in T-tubular electrical activity underlie local alterations of calcium release in heart failure 171
Novel blockers of hyperpolarization-activated current with isoform selectivity in recombinant cells and native tissue. 169
n-3 polyunsaturated fatty acid supplementation reduces asymmetric dimethylarginine and arachidonate accumulation in spontaneously hypertensive rats 167
The Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels: from Biophysics to Pharmacology of a Unique Family of Ion Channels 167
Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin 166
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function 165
Photoresponsive Polymer-Based Biomimetic Contractile Units as Building Block for Artificial Muscles 165
Beta1 and Beta2 adrenoceptors in human ventricular myocytes: a study of their proportion and signaling pathways. 165
Totale 22.742
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.456
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021206 0 0 0 0 0 0 0 0 0 0 0 206
2021/20222.066 56 183 171 83 92 107 93 129 123 95 356 578
2022/20234.834 475 904 185 308 426 894 579 241 527 43 135 117
2023/20241.694 96 224 307 88 105 195 84 320 28 63 91 93
2024/202512.017 442 1.373 842 1.724 3.209 1.526 217 838 632 314 466 434
2025/202614.580 1.334 1.920 1.067 1.134 1.509 712 1.767 812 1.113 888 402 1.922
Totale 46.771